Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.

Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C, Beer A, Kamphues C, Løes IM, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Cameron JL, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

Ann Surg. 2019 Jun;269(6):1129-1137. doi: 10.1097/SLA.0000000000002664.

PMID:
31082912
2.

KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases.

Margonis GA, Amini N, Andreatos N, Sasaki K, McVey J, Mirza MB, Warner S, Buettner S, Barbon C, Wang J, Pulvirenti A, Angelou A, Kamphues C, Antoniou E, Pikoulis E, Pawlik TM, Kaczirek K, Poultsides G, Wagner D, Endo I, Imai K, Aucejo F, Kreis ME, Wolfgang CL, Weiss MJ.

HPB (Oxford). 2019 Apr 9. pii: S1365-182X(19)30493-9. doi: 10.1016/j.hpb.2019.03.368. [Epub ahead of print]

PMID:
30979646
3.

Response to the Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."

Margonis GA, Andreatos N, Wolfgang CL, Weiss MJ.

Ann Surg. 2019 Apr;269(4):e49-e51. doi: 10.1097/SLA.0000000000002858. No abstract available.

PMID:
30845013
4.

A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae.

Tansarli GS, Andreatos N, Pliakos EE, Mylonakis E.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02495-18. doi: 10.1128/AAC.02495-18. Print 2019 May.

PMID:
30803971
5.

Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.

Oshi M, Margonis GA, Sawada Y, Andreatos N, He J, Kumamoto T, Morioka D, Wolfgang CL, Tanaka K, Weiss MJ, Endo I.

Ann Surg Oncol. 2019 Feb;26(2):593-603. doi: 10.1245/s10434-018-6830-x. Epub 2018 Nov 27.

PMID:
30483976
6.

The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia.

Pliakos EE, Andreatos N, Tansarli GS, Ziakas PD, Mylonakis E.

Chest. 2019 Apr;155(4):787-794. doi: 10.1016/j.chest.2018.11.001. Epub 2018 Nov 15.

PMID:
30448195
7.

Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.

Masuda T, Margonis GA, Andreatos N, Wang J, Warner S, Mirza MB, Angelou A, Damaskos C, Garmpis N, Sasaki K, He J, Imai K, Yamashita YI, Wolfgang CL, Baba H, Weiss MJ.

Anticancer Res. 2018 Nov;38(11):6353-6360. doi: 10.21873/anticanres.12993.

PMID:
30396957
8.

Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations? delivery systems.

Garmpi A, Garmpis N, Damaskos C, Valsami S, Spartalis E, Lavaris A, Patelis N, Margonis GA, Apostolou KG, Spartalis M, Andreatos N, Diamantis E, Tsivelekas K, Moschos MM, Nonni A, Tsourouflis G, Markatos K, Antoniou EA, Kontzoglou K, Nikiteas N, Dimitroulis D.

J BUON. 2018 Jul-Aug;23(4):846-861.

9.

The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.

Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Galjart B, Kamphues C, Pawlik TM, Poultsides G, Kaczirek K, Lønning PE, Verhoef C, Kreis ME, Wolfgang CL, Weiss MJ.

J Surg Oncol. 2018 Dec;118(7):1074-1080. doi: 10.1002/jso.25251. Epub 2018 Sep 27.

PMID:
30261094
10.

BRAF V600E Mutation as a Negative Prognostic Determinant in Resected Colorectal Liver Metastases-Reply.

Margonis GA, Andreatos N, Weiss MJ.

JAMA Surg. 2018 Sep 12. doi: 10.1001/jamasurg.2018.3339. [Epub ahead of print] No abstract available.

PMID:
30208387
11.

The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections.

Pliakos EE, Andreatos N, Ziakas PD, Mylonakis E.

Clin Infect Dis. 2019 Jan 18;68(3):419-425. doi: 10.1093/cid/ciy511.

PMID:
29945237
12.

Reply to: "Precision Surgery" for Colorectal Liver Metastases: is the Time Ripe?"

Margonis GA, Andreatos N, Wolfgang CL, Weiss MJ.

Ann Surg. 2018 Jun 18. doi: 10.1097/SLA.0000000000002858. [Epub ahead of print] No abstract available.

PMID:
29916883
13.

Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma.

Sasaki K, Margonis GA, Andreatos N, Chen Q, Barbon C, Bagante F, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Groot Koerkamp B, Guglielmi A, Endo I, Aucejo FN, Pawlik TM.

HPB (Oxford). 2018 Oct;20(10):956-965. doi: 10.1016/j.hpb.2018.04.005. Epub 2018 Jun 8.

PMID:
29887261
14.

Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection".

Margonis GA, Andreatos N, Wolfgang CL, Weiss MJ.

Ann Surg. 2019 Jan;269(1):e4-e5. doi: 10.1097/SLA.0000000000002846. No abstract available.

PMID:
29864095
15.

The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.

Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E.

Clin Microbiol Rev. 2018 May 30;31(3). pii: e00095-17. doi: 10.1128/CMR.00095-17. Print 2018 Jul. Review.

16.

A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.

Angelou A, Andreatos N, Antoniou E, Zacharioudaki A, Theodoropoulos G, Damaskos C, Garmpis N, Yuan C, Xiao W, Theocharis S, Zografos G, Papalois A, Margonis GA.

Anticancer Res. 2018 Jun;38(6):3467-3470. doi: 10.21873/anticanres.12616.

PMID:
29848698
17.

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.

Margonis GA, Buettner S, Andreatos N, Kim Y, Wagner D, Sasaki K, Beer A, Schwarz C, Løes IM, Smolle M, Kamphues C, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Cameron JL, Burkhart RA, Gerger A, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996. Epub 2018 Jul 18.

18.

Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.

Deshwar A, Margonis GA, Andreatos N, Barbon C, Wang J, Buettner S, Wagner D, Sasaki K, Beer A, Løes IM, Pikoulis E, Damaskos C, Garmpis N, Kamphues K, He J, Kaczirek K, Poultsides G, Lønning PE, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

Anticancer Res. 2018 May;38(5):2891-2895.

PMID:
29715113
19.

Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D'Angelica MI, Weiss MJ.

Br J Surg. 2018 Aug;105(9):1210-1220. doi: 10.1002/bjs.10838. Epub 2018 Apr 25.

PMID:
29691844
20.

The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis.

Andreatos N, Shehadeh F, Pliakos EE, Mylonakis E.

Int J Antimicrob Agents. 2018 Aug;52(2):195-200. doi: 10.1016/j.ijantimicag.2018.04.003. Epub 2018 Apr 12.

PMID:
29656062
21.

Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?

Barbon C, Margonis GA, Andreatos N, Rezaee N, Sasaki K, Buettner S, Damaskos C, Pawlik TM, He J, Wolfgang CL, Weiss MJ.

J Gastrointest Surg. 2018 Jul;22(7):1286-1296. doi: 10.1007/s11605-018-3766-1. Epub 2018 Apr 11.

PMID:
29644557
22.

The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Wang J, Margonis GA, Amini N, Andreatos N, Yuan C, Damaskos C, Antoniou E, Garmpis N, Buettner S, Barbon C, Deshwar A, He J, Burkhart R, Pawlik TM, Wolfgang CL, Weiss MJ.

J Gastrointest Surg. 2018 Aug;22(8):1350-1357. doi: 10.1007/s11605-018-3748-3. Epub 2018 Apr 9.

PMID:
29633114
23.

Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile.

Araos R, Andreatos N, Ugalde J, Mitchell S, Mylonakis E, D'Agata EMC.

Dig Dis Sci. 2018 Jun;63(6):1525-1531. doi: 10.1007/s10620-018-5030-7. Epub 2018 Mar 28.

24.

Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?

Garmpis N, Damaskos C, Garmpi A, Spartalis E, Kalampokas E, Kalampokas T, Margonis GA, Schizas D, Andreatos N, Angelou A, Lavaris A, Athanasiou A, Apostolou KG, Spartalis M, Damaskou Z, Daskalopoulou A, Diamantis E, Tsivelekas K, Alavanos A, Valsami S, Moschos MM, Sampani A, Nonni A, Antoniou EA, Mantas D, Tsourouflis G, Markatos K, Kontzoglou K, Perrea D, Nikiteas N, Kostakis A, Dimitroulis D.

Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):950-960. doi: 10.26355/eurrev_201802_14376.

PMID:
29509243
25.

Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma.

Sasaki K, Shindoh J, Nishioka Y, Sugawara T, Margonis GA, Andreatos N, Pawlik TM, Hashimoto M.

J Surg Oncol. 2018 Apr;117(5):902-911. doi: 10.1002/jso.25015. Epub 2018 Feb 23.

PMID:
29473962
26.

Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.

Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C, Beer A, Kamphues C, Løes IM, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Cameron JL, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

Ann Surg. 2018 Jan 18. doi: 10.1097/SLA.0000000000002664. [Epub ahead of print]

PMID:
29351098
27.

Systemic treatment and primary tumor location in patients with metastatic colorectal cancer.

Antoniou E, Andreatos N, Margonis GA, Papalois A, Wang J, Damaskos C, Garmpis N, Buettner S, Deshwar A, Pappas V, Weiss MJ, Pawlik TM, Pikoulis E.

J BUON. 2017 Nov-Dec;22(6):1447-1456.

28.

Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?

Damaskos C, Tomos I, Garmpis N, Karakatsani A, Dimitroulis D, Garmpi A, Spartalis E, Kampolis CF, Tsagkari E, Loukeri AA, Margonis GA, Spartalis M, Andreatos N, Schizas D, Kokkineli S, Antoniou EA, Nonni A, Tsourouflis G, Markatos K, Kontzoglou K, Kostakis A, Tomos P.

Anticancer Res. 2018 Jan;38(1):37-43. Review.

PMID:
29277754
29.

Effect of Increased Intra-abdominal Pressure on Liver Histology and Hemodynamics: An Experimental Study.

Antoniou EA, Kairi E, Margonis GA, Andreatos N, Sasaki K, Damaskos C, Garmpis N, Samaha M, Argyra E, Polymeneas G, Weiss MJ, Pawlik TM, Voros D, Kouraklis G.

In Vivo. 2018 Jan-Feb;32(1):85-91.

30.

Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.

Sasaki K, Margonis GA, Andreatos N, Bagante F, Weiss M, Barbon C, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Itaru E, Aucejo FN, Pawlik TM.

J Am Coll Surg. 2018 Apr;226(4):393-403. doi: 10.1016/j.jamcollsurg.2017.12.011. Epub 2017 Dec 21.

PMID:
29274841
31.

Inappropriate Management of Asymptomatic Patients With Positive Urine Cultures: A Systematic Review and Meta-analysis.

Flokas ME, Andreatos N, Alevizakos M, Kalbasi A, Onur P, Mylonakis E.

Open Forum Infect Dis. 2017 Nov 20;4(4):ofx207. doi: 10.1093/ofid/ofx207. eCollection 2017 Fall.

32.

Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis.

Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, Psaltopoulou T, Wang J, Buettner S, Papalois ΑE, He J, Wolfgang CL, Pawlik TM, Weiss MJ.

Ann Surg. 2018 Jun;267(6):1047-1055. doi: 10.1097/SLA.0000000000002552.

PMID:
29189379
33.

Cystic hygroma of the neck: single center experience and literature review.

Damaskos C, Garmpis N, Manousi M, Garmpi A, Margonis GA, Spartalis E, Doula C, Michail-Strantzia C, Patelis N, Schizas D, Arkoumanis PT, Andreatos N, Tsourouflis G, Zavras N, Markatos K, Kontzoglou K, Antoniou EA.

Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4918-4923. Review.

34.

Angiomyolipoma of the Liver: A Rare Benign Tumor Treated with a Laparoscopic Approach for the First Time.

Damaskos C, Garmpis N, Garmpi A, Nonni A, Sakellariou S, Margonis GA, Spartalis E, Schizas D, Andreatos N, Magkouti E, Grivas A, Kontzoglou K, Weiss MJ, Antoniou EA.

In Vivo. 2017 Nov-Dec;31(6):1169-1173.

35.

Triple therapy reduced mortality more than oseltamivir alone in patients admitted for severe influenza infection.

Andreatos N, Mylonakis E.

Ann Intern Med. 2017 Oct 17;167(8):JC41. doi: 10.7326/ACPJC-2017-167-8-041. No abstract available.

PMID:
29049760
36.

Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?

Garmpis N, Damaskos C, Garmpi A, Dimitroulis D, Spartalis E, Margonis GA, Schizas D, Deskou I, Doula C, Magkouti E, Andreatos N, Antoniou EA, Nonni A, Kontzoglou K, Mantas D.

Anticancer Res. 2017 Oct;37(10):5355-5362. Review.

PMID:
28982843
37.

The salivary microbiome is consistent between subjects and resistant to impacts of short-term hospitalization.

Cabral DJ, Wurster JI, Flokas ME, Alevizakos M, Zabat M, Korry BJ, Rowan AD, Sano WH, Andreatos N, Ducharme RB, Chan PA, Mylonakis E, Fuchs BB, Belenky P.

Sci Rep. 2017 Sep 8;7(1):11040. doi: 10.1038/s41598-017-11427-2.

38.

The impact of HIV infection and socioeconomic factors on the incidence of gonorrhea: A county-level, US-wide analysis.

Andreatos N, Grigoras C, Shehadeh F, Pliakos EE, Stoukides G, Port J, Flokas ME, Mylonakis E.

PLoS One. 2017 Sep 1;12(9):e0183938. doi: 10.1371/journal.pone.0183938. eCollection 2017.

39.

Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis.

Flokas ME, Alevizakos M, Shehadeh F, Andreatos N, Mylonakis E.

Int J Antimicrob Agents. 2017 Nov;50(5):649-656. doi: 10.1016/j.ijantimicag.2017.08.003. Epub 2017 Aug 3. Review.

PMID:
28782707
40.

The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis.

Andreatos N, Flokas ME, Apostolopoulou A, Alevizakos M, Mylonakis E.

Open Forum Infect Dis. 2017 May 24;4(3):ofx113. doi: 10.1093/ofid/ofx113. eCollection 2017 Summer.

41.

Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.

Margonis GA, Buettner S, Andreatos N, Sasaki K, Pour MZ, Deshwar A, Wang J, Ghasebeh MA, Damaskos C, Rezaee N, Pawlik TM, Wolfgang CL, Kamel IR, Weiss MJ.

J Surg Oncol. 2017 Dec;116(8):1150-1158. doi: 10.1002/jso.24769. Epub 2017 Jul 25.

PMID:
28743167
42.

Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.

Alevizakos M, Gaitanidis A, Andreatos N, Arunachalam K, Flokas ME, Mylonakis E.

Int J Antimicrob Agents. 2017 Nov;50(5):657-663. doi: 10.1016/j.ijantimicag.2017.07.003. Epub 2017 Jul 10. Review.

PMID:
28705665
43.

The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion.

Sasaki K, Margonis GA, Maitani K, Andreatos N, Wang J, Pikoulis E, He J, Wolfgang CL, Weiss M, Pawlik TM.

Ann Surg Oncol. 2017 Sep;24(9):2438-2446. doi: 10.1245/s10434-017-5904-5. Epub 2017 Jul 10.

PMID:
28695393
44.

Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.

Margonis GA, Buettner S, Andreatos N, Sasaki K, Ijzermans JNM, van Vugt JLA, Pawlik TM, Choti MA, Cameron JL, He J, Wolfgang CL, Weiss MJ.

Ann Surg. 2017 Oct;266(4):641-649. doi: 10.1097/SLA.0000000000002367.

PMID:
28657938
45.

Solid Pseudopapillary Tumor of the Pancreas: A Single-center Experience and Review of the Literature.

Antoniou EA, Damaskos C, Garmpis N, Salakos C, Margonis GA, Kontzoglou K, Lahanis S, Spartalis E, Patsouras D, Kykalos S, Garmpi A, Andreatos N, Pawlik TM, Kouraklis G.

In Vivo. 2017 Jul-Aug;31(4):501-510. Review.

46.

Increased kinetic growth rate during late phase liver regeneration impacts the risk of tumor recurrence after colorectal liver metastases resection.

Margonis GA, Sasaki K, Andreatos N, Pour MZ, Shao N, Ghasebeh MA, Buettner S, Antoniou E, Wolfgang CL, Weiss M, Kamel IR, Pawlik TM.

HPB (Oxford). 2017 Sep;19(9):808-817. doi: 10.1016/j.hpb.2017.05.002. Epub 2017 Jun 9.

47.

The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.

Sasaki K, Margonis GA, Andreatos N, Zhang XF, Buettner S, Wang J, Deshwar A, He J, Wolfgang CL, Weiss M, Pawlik TM.

J Surg Oncol. 2017 Sep;116(4):515-523. doi: 10.1002/jso.24678. Epub 2017 May 25.

PMID:
28543544
48.

Consideration of KRAS Mutational Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET Scan, in Patients With Colorectal Liver Metastases.

Margonis GA, Andreatos N, Pawlik TM, Weiss MJ.

Ann Surg. 2018 Jul;268(1):e8-e9. doi: 10.1097/SLA.0000000000002264. No abstract available.

PMID:
28448388
49.

Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.

Sasaki K, Margonis GA, Andreatos N, Wilson A, Weiss M, Wolfgang C, Sergentanis TN, Polychronidis G, He J, Pawlik TM.

Br J Surg. 2017 Jun;104(7):926-935. doi: 10.1002/bjs.10510. Epub 2017 Mar 7.

PMID:
28266705
50.

Prognostic impact of complications after resection of early stage hepatocellular carcinoma.

Margonis GA, Sasaki K, Andreatos N, Nishioka Y, Sugawara T, Amini N, Buettner S, Hashimoto M, Shindoh J, Pawlik TM.

J Surg Oncol. 2017 Jun;115(7):791-804. doi: 10.1002/jso.24576. Epub 2017 Feb 15.

PMID:
28205284

Supplemental Content

Loading ...
Support Center